All Stories

  1. Kidney Impairment and α-Synucleinopathy
  2. Delirium Guideline Recommendations
  3. Medicare Provider Pro's & Con's
  4. Why independent practice healthcare professionals can't unionize
  5. Consequences of U.S. COVID-19 Policy in 2024
  6. Auvelity as a Potential Treatment for Alzheimer’s Disease
  7. Ageism, Mentalism, and Ableism Shape Telehealth Policy
  8. U.S. COVID-19 Policy in 2023
  9. Assessing Delirium at Hospital Discharge
  10. Research Aspects in Biological Science Vol. 9
  11. Donepezil and α‐synuclein Constipation: A 60 Month Follow-Up
  12. Brief test to assess IT use
  13. Donepezil and \(\alpha\) -synuclein Constipation: A Longitudinal Study
  14. Update on the Functional Assessment of Currently Employed Technology Scale (FACETS) 4.0
  15. Reliability and Validity of the Functional Assessment of Currently Employed Technology Scale (FACETS)
  16. Telehealth Policy and Access to Care
  17. U.S. COVID-19 Policy: Politics Trump Science
  18. Auvelity as a Potential Treatment for Alzheimer’s Disease
  19. COVID-19, Telehealth and Access to Care
  20. Donepezil and α-synuclein Constipation: A 48 Month Follow-Up
  21. Telehealth Reimbursement Allows Access to Mental Health Care During COVID-19
  22. Functional Assessment Of Currently Employed Technology Scale (FACETS) 4.0: Update On A Brief Intake Instrument To Facilitate Treatment Planning And Communication With Patients
  23. Prevalence and Treatment of Constipation in Patients with Alpha-Synuclein Pathology
  24. Donepezil and α-synuclein Constipation: A 36 Month Follow-Up
  25. The internet: Barrier to health care for older adults?
  26. Donepezil for α‐synuclein Constipation: An 18 Month Follow-Up
  27. Donepezil for Constipation in Lewy Body Disease: A Twelve-Month Follow-Up
  28. Multidisciplinary care model for older adults
  29. Mechanisms of α‐Synuclein Pathology and Treatment in the Enteric Nervous System
  30. Donepezil for Constipation in Lewy Body Diseases: Four Case Studies
  31. Donepezil for Lewy Body Constipation: A Six-Month Follow-up
  32. Medications linked to cognitive impairment in older adults
  33. Neurocognitive disorder with Lewy bodies: Evidence-based diagnosis and treatment.
  34. The clinical pharmacology of paroxetine in healthy subjects
  35. An empirical assessment of bulimic patients using multiple measures
  36. Gender and Sex-Role Orientation Effects on Friendship Choice
  37. Evoked Potential Correlates of Genetic Progressive Hearing Loss: Age-related Changes from the Ear to the Inferior Colliculus of C57BL/6 and CBA/J Mice